Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001030784 | SCV003241835 | pathogenic | Hereditary spastic paraplegia 45 | 2022-05-12 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 810633). This premature translational stop signal has been observed in individual(s) with clinical features of NT5C2-related conditions (PMID: 32214227). This variant is present in population databases (rs764453448, gnomAD 0.01%). This sequence change creates a premature translational stop signal (p.Arg144*) in the NT5C2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in NT5C2 are known to be pathogenic (PMID: 24482476). |
Section for Clinical Neurogenetics, |
RCV001030784 | SCV001156094 | likely pathogenic | Hereditary spastic paraplegia 45 | 2019-08-01 | no assertion criteria provided | research |